Max Rady College of Medicine
Room 401 - 727 McDermot Avenue
University of Manitoba
Winnipeg, Manitoba R3E 0W2
Dr. John Gartner’s current research focuses on the application of structural genomic approaches to risk stratification in cancer through close collaboration with Dr. Sabine Mai at CancerCare Manitoba. His team is using 3D-telomere profiling and superresolution microscopic examination of nuclear DNA structure.
Dr. John Gartner is a professor of pathology in Rady Faculty of Health Sciences, University of Manitoba.
As a clinician scientist he has been active in both clinical practice and research. His clinical focus is in general surgical pathology with a specialty interest in kidney pathology.
Following my training in pathology he obtained a MRC fellowship to pursue my research interest in transplantation immunology. From 1983-2015, his research program focused on the immunopathogenesis of graft versus host disease. From 2005-2015, he served as head of pathology at the University of Manitoba.
At the end of his term he recalibrated my research focus and he is now actively engaged in collaborative research with Dr. Sabine Mai on the application of structural genomic changes to stratify risk of tumor progression in neuroblastoma, and cancers of the thyroid and kidney.
Over the course of his career he has trained two PhD students, four master’s students, and several post-doctoral fellows.
His total career funding from both national and local research funding agencies is $3,102,700 to date. He currently holds grants as a co-principal investigator with Dr. Mai.